These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Effects of sphingosine 1-phosphate on functions of T cell - review]. Huang WR; Wang LS; DA WM Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):718-22. PubMed ID: 16129068 [TBL] [Abstract][Full Text] [Related]
4. Immunology. The sources of a lipid conundrum. Chun J Science; 2007 Apr; 316(5822):208-10. PubMed ID: 17431159 [No Abstract] [Full Text] [Related]
5. Targeting sphingosine-1-phosphate in hematologic malignancies. Stevenson CE; Takabe K; Nagahashi M; Milstien S; Spiegel S Anticancer Agents Med Chem; 2011 Nov; 11(9):794-8. PubMed ID: 21707492 [TBL] [Abstract][Full Text] [Related]
11. Focus on molecules: Sphingosine 1 Phosphate (S1P). Gupta VK; You Y; Klistorner A; Graham SL Exp Eye Res; 2012 Oct; 103():119-20. PubMed ID: 22001715 [No Abstract] [Full Text] [Related]
12. [Research progress of the selective sphingosine-1-phosphate receptor 1 agonists]. Tian YL; Jin J; Wang XJ Yao Xue Xue Bao; 2012 Jan; 47(1):7-17. PubMed ID: 22493799 [TBL] [Abstract][Full Text] [Related]
13. The outs and the ins of sphingosine-1-phosphate in immunity. Spiegel S; Milstien S Nat Rev Immunol; 2011 Jun; 11(6):403-15. PubMed ID: 21546914 [TBL] [Abstract][Full Text] [Related]
14. Mrp1 is essential for sphingolipid signaling to p-glycoprotein in mouse blood-brain and blood-spinal cord barriers. Cartwright TA; Campos CR; Cannon RE; Miller DS J Cereb Blood Flow Metab; 2013 Mar; 33(3):381-8. PubMed ID: 23168528 [TBL] [Abstract][Full Text] [Related]
15. A role for S1P and S1P1 in immature-B cell egress from mouse bone marrow. Pereira JP; Xu Y; Cyster JG PLoS One; 2010 Feb; 5(2):e9277. PubMed ID: 20174580 [TBL] [Abstract][Full Text] [Related]
16. Sphingosine 1-phosphate (S1P): Physiology and the effects of S1P receptor modulation. Hla T; Brinkmann V Neurology; 2011 Feb; 76(8 Suppl 3):S3-8. PubMed ID: 21339489 [TBL] [Abstract][Full Text] [Related]
17. Production and release of sphingosine 1-phosphate and the phosphorylated form of the immunomodulator FTY720. Kihara A; Igarashi Y Biochim Biophys Acta; 2008 Sep; 1781(9):496-502. PubMed ID: 18555808 [TBL] [Abstract][Full Text] [Related]
18. Second generation S1P pathway modulators: research strategies and clinical developments. Bigaud M; Guerini D; Billich A; Bassilana F; Brinkmann V Biochim Biophys Acta; 2014 May; 1841(5):745-58. PubMed ID: 24239768 [TBL] [Abstract][Full Text] [Related]
19. Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis. Mehling M; Johnson TA; Antel J; Kappos L; Bar-Or A Neurology; 2011 Feb; 76(8 Suppl 3):S20-7. PubMed ID: 21339487 [TBL] [Abstract][Full Text] [Related]